Novel therapeutic strategies leveraging TH9 cell anticancer functions. Jiazhi Xu
Semin Immunol. 2026 Apr 16;82:102026. doi: 10.1016/j.smim.2026.102026. Online ahead of print. ABSTRACT TH9 cells, a distinct subset of CD4+ T helper cells characterized by IL-9 production, have emerged as key players in cancer immunology. Initially recognized for their potent antitumor activity upon adoptive cell transfer against melanoma, recent studies have revealed a more complex and … Read more